These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 23776095)

  • 1. Association of antidepressant and atypical antipsychotic use with cardiovascular events and mortality in a veteran population.
    Acharya T; Acharya S; Tringali S; Huang J
    Pharmacotherapy; 2013 Oct; 33(10):1053-61. PubMed ID: 23776095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining mirtazapine with SSRIs or SNRIs for treatment-resistant depression: the MIR RCT.
    Kessler D; Burns A; Tallon D; Lewis G; MacNeill S; Round J; Hollingworth W; Chew-Graham C; Anderson I; Campbell J; Dickens C; Macleod U; Gilbody S; Davies S; Peters TJ; Wiles N
    Health Technol Assess; 2018 Nov; 22(63):1-136. PubMed ID: 30468145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of atypical antipsychotics in depressive syndromes].
    Quintin P; Thomas P
    Encephale; 2004; 30(6):583-9. PubMed ID: 15738862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology of antidepressants: selectivity or multiplicity?
    Westenberg HG
    J Clin Psychiatry; 1999; 60 Suppl 17():4-8; discussion 46-8. PubMed ID: 10446734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative assessment of adherence measures and resource use in SSRI/SNRI-treated patients with depression using second-generation antipsychotics or L-methylfolate as adjunctive therapy.
    Wade RL; Kindermann SL; Hou Q; Thase ME
    J Manag Care Pharm; 2014 Jan; 20(1):76-85. PubMed ID: 24372461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations.
    Sung SC; Haley CL; Wisniewski SR; Fava M; Nierenberg AA; Warden D; Morris DW; Kurian BT; Trivedi MH; Rush AJ;
    J Clin Psychiatry; 2012 Jul; 73(7):967-76. PubMed ID: 22687487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Other Antidepressants.
    Schwasinger-Schmidt TE; Macaluso M
    Handb Exp Pharmacol; 2019; 250():325-355. PubMed ID: 30194544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of augmented atypical antipsychotics on weight change in patients with major depressive disorder in a naturalistic setting.
    Seo HJ; Jung YE; Woo YS; Jun TY; Chae JH; Bahk WM
    Hum Psychopharmacol; 2009 Mar; 24(2):135-43. PubMed ID: 19156709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of the safety and harms of antidepressant drugs for older people: a cohort study using a large primary care database.
    Coupland CA; Dhiman P; Barton G; Morriss R; Arthur A; Sach T; Hippisley-Cox J
    Health Technol Assess; 2011 Aug; 15(28):1-202, iii-iv. PubMed ID: 21810375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lithium or an atypical antipsychotic drug in the management of treatment-resistant depression: a systematic review and economic evaluation.
    Edwards SJ; Hamilton V; Nherera L; Trevor N
    Health Technol Assess; 2013 Nov; 17(54):1-190. PubMed ID: 24284258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mirtazapine: a review of its use in major depression.
    Holm KJ; Markham A
    Drugs; 1999 Apr; 57(4):607-31. PubMed ID: 10235695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SIADH with multiple antidepressants in a geriatric patient.
    Blass DM; Pearson VE
    J Clin Psychiatry; 2000 Jun; 61(6):448-9. PubMed ID: 10901346
    [No Abstract]   [Full Text] [Related]  

  • 13. SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression.
    Kent JM
    Lancet; 2000 Mar; 355(9207):911-8. PubMed ID: 10752718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of mirtazapine in difficult-to-treat patient populations.
    Hirschfeld RM
    Hum Psychopharmacol; 2002 Jun; 17 Suppl 1():S33-6. PubMed ID: 12404668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents.
    Papakostas GI; Thase ME; Fava M; Nelson JC; Shelton RC
    Biol Psychiatry; 2007 Dec; 62(11):1217-27. PubMed ID: 17588546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mirtazapine is associated with less anxiolytic use among elderly depressed patients in long-term care facilities.
    Gardner ME; Malone DC; Sey M; Babington MA
    J Am Med Dir Assoc; 2004; 5(2):101-6. PubMed ID: 14984621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non response at week 4 as clinically useful indicator for antidepressant combination in major depressive disorder. A sequential RCT.
    Kato M; Takekita Y; Koshikawa Y; Sakai S; Bandou H; Nishida K; Sunada N; Onohara A; Hatashita Y; Serretti A; Kinoshita T
    J Psychiatr Res; 2017 Jun; 89():97-104. PubMed ID: 28213170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline depression severity as a predictor of single and combination antidepressant treatment outcome: results from the CO-MED trial.
    Friedman ES; Davis LL; Zisook S; Wisniewski SR; Trivedi MH; Fava M; Rush AJ;
    Eur Neuropsychopharmacol; 2012 Mar; 22(3):183-99. PubMed ID: 21920711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible neurobiological mechanisms underlying faster onset of antidepressant action.
    Blier P
    J Clin Psychiatry; 2001; 62 Suppl 4():7-11; discussion 37-40. PubMed ID: 11229789
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.